» Articles » PMID: 36047170

Population Analysis of Oseltamivir-resistant Variants for the Rapid Prediction of Drug Susceptibility by Real-time Reverse Transcription Polymerase Chain Reaction

Overview
Specialty General Medicine
Date 2022 Sep 1
PMID 36047170
Authors
Affiliations
Soon will be listed here.
Abstract

This study investigated whether quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR), using specific probes composed of locked nucleic acids (LNA/qRT-PCR), designed to evaluate H1N1 pdm09 H275Y, H3N2 E119V and R292K variant populations, could replace a neuraminidase (NA) inhibition assay to determine the 50% inhibitory concentration (IC) of NA activity.For H1N1 pdm09, when the H275Y variant RNA load was 50% or 70% and the infective H275Y variant load was 40% or 70%, the IC were >10- and 100-fold higher, respectively, than that of the wild-type (WT) strain. For H3N2, when the E119V RNA load and infective E119V variant load were >90% and >60%, respectively, the IC of the mixed sample was >10-fold higher than that of the WT strain. The variant-mixed samples with a 70% or 80% R292K variant RNA load and a 60% or 70% infective R292K variant load exhibited >10- and 100-fold decreased susceptibility, respectively, compared with that of the WT. A positive correlation between the variant RNA load and infective variant load populations was observed.The LNA/qRT-PCR method can be used to improve the treatment and management of patients during antiviral therapy for influenza virus infection.

References
1.
Takashita E, Kiso M, Fujisaki S, Yokoyama M, Nakamura K, Shirakura M . Characterization of a large cluster of influenza A(H1N1)pdm09 viruses cross-resistant to oseltamivir and peramivir during the 2013-2014 influenza season in Japan. Antimicrob Agents Chemother. 2015; 59(5):2607-17. PMC: 4394804. DOI: 10.1128/AAC.04836-14. View

2.
Tashiro M, McKimm-Breschkin J, Saito T, Klimov A, Macken C, Zambon M . Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996-2007. Antivir Ther. 2009; 14(6):751-61. DOI: 10.3851/IMP1194. View

3.
van der Vries E, Jonges M, Herfst S, Maaskant J, van der Linden A, Guldemeester J . Evaluation of a rapid molecular algorithm for detection of pandemic influenza A (H1N1) 2009 virus and screening for a key oseltamivir resistance (H275Y) substitution in neuraminidase. J Clin Virol. 2009; 47(1):34-7. PMC: 7185517. DOI: 10.1016/j.jcv.2009.09.030. View

4.
Okomo-Adhiambo M, Nguyen H, Elal A, Sleeman K, Fry A, Gubareva L . Drug susceptibility surveillance of influenza viruses circulating in the United States in 2011-2012: application of the WHO antiviral working group criteria. Influenza Other Respir Viruses. 2013; 8(2):258-65. PMC: 4186475. DOI: 10.1111/irv.12215. View

5.
Ghedin E, Laplante J, DePasse J, Wentworth D, Santos R, Lepow M . Deep sequencing reveals mixed infection with 2009 pandemic influenza A (H1N1) virus strains and the emergence of oseltamivir resistance. J Infect Dis. 2011; 203(2):168-74. PMC: 3071067. DOI: 10.1093/infdis/jiq040. View